CVBF – Consorzio per Valutazioni Biologiche e Farmacologiche

Consorzio per Valutazioni Biologiche e Farmacologiche (CVBF) is a not-for-profit organisation, founded in 2000 with the mission to perform research and provide scientific, economic and regulatory consultancy for innovation in the health sector at European level. The main fields of interest are life sciences and biotechnologies, drug development for small populations (pediatric and rare diseases), research management andmethodology, monitoring, statistics, regulatory, ethics and pharmacovigilance.

Who we are

About

Mission

Consortium

CVBF Albania

Accreditations

Activities

Scientific Research

Development and application of innovative methodologies in clinical trials for small populations, management of disease registries, execution of studies in the pharmacological field. Find out more.

Regulatory Activities

Development and supervision of dossiers and documentation regarding national and European authorisation procedures for medicinal products. Find out more.

Clinical Trials

Development and management of all clinical trial phases, which are performed by the Consortium both as a Sponsor and as a Contract Research Organisation (CRO). Find out more.

Training

Educational activities addressed to public bodies, research institutes and private companies, also within CME programmes. Find out more.

Project Management

Management and participation to medical research projects and consortiums at national and international level. Find out more.

Databases

Design and management of registries and drug databases. Find out more.

Networking

Research networks aimed to facilitate transfer of know-how and to promote national and international research as well as scientific excellence. Find out more.

CVBF Brochure

On-going Projects

Latest News

2004, 2018

CVBF included by Financial Times in the list of the 1000 Europe’s Fastest-Growing Companies

We are proud to announce that CVBF has been included in the Financial Times (FT) 1000 repot, a list of the companies in 31 European countries that have achieved the highest percentage growth in revenues between [...]

604, 2018

CVBF as EMA stakeholder at the Second International Awareness Session for International regulators, academia and non-governamental organisations

On 8-9 March 2018, the European Medicines Agency (EMA) held “the Second International Awareness Session for international regulators, academia and non-governmental organisations”. The meeting provided the occasion to present an overall overview on how the European [...]